Vimpat and Scleroderma - from FDA reports
Scleroderma is reported only by a few people who take Vimpat. We study 6,728 people who have side effects while taking Vimpat from FDA. Among them, 1 have Scleroderma. Find out below who they are, when they have Scleroderma and more.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 22, 2017
6,728 people reported to have side effects when taking Vimpat.
Among them, 1 person (0.01%) has Scleroderma
Number of reports submitted per year:
Time on Vimpat when people have Scleroderma *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Scleroderma when taking Vimpat *:
- female: 100 %
- male: 0.0 %
Age of people who have Scleroderma when taking Vimpat *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Top conditions involved for these people *:
- Partial Seizures (1 person, 100.00%)
Top co-used drugs for these people *:
- Topiramate (1 person, 100.00%)
- Lamotrigine (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Scleroderma when taking Vimpat?
Vimpat has active ingredients of lacosamide. It is often used in epilepsy. (latest outcomes from Vimpat 6,862 users)
Scleroderma (hard skin) has been reported by people with primary pulmonary hypertension, pulmonary hypertension, systemic sclerosis (scleroderma), rheumatoid arthritis, osteoporosis (latest reports from 6,356 Scleroderma patients).